Article Text

Download PDFPDF
Ossifying fibromyxoid tumor: a rare case
  1. Masood Umer1,
  2. Javeria Saeed1,
  3. Nasir Ud Din2 and
  4. Kiran Hilal3
  1. 1 Department of Surgery, Aga Khan University, Karachi, Sindh, Pakistan
  2. 2 Pathology, Aga Khan University, Karachi, Sindh, Pakistan
  3. 3 Radiology, Aga Khan University, Karachi, Sindh, Pakistan
  1. Correspondence to Ms Javeria Saeed, javeria.saeed{at}


Ossifying fibromyxoid tumour (OFMT) is a rarely occurring soft tissue neoplasm of mesenchymal origin. It is a rarely found tumour with intermediate behaviour and differentiation. Although it is mostly benign, malignant variants also exist. We are presenting a case of 32-year-old man presented in clinic with complaints of painless swelling in left distal thigh. After reviewing his X-ray, a diagnostic biopsy was planned which came out to be suspicious of solitary fibrous tumour. Other radiological workup was done and the patient was planned to undergo wide margin excision. The final histopathology showed a diagnosis of OFMT of soft tissue, atypical variant. The patient is under follow-up and is disease free. This type of tumour possesses potential of local recurrence and metastases; therefore, it is important to keep a long-term follow-up of patient.

  • surgical oncology
  • orthopaedic and trauma surgery

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors have equally contributed to the manuscript. MU proposed the idea and finally reviewed the paper. JS contributed in literature search, writing of manuscript and making final changes. NUD contributed in writing of all histopathology aspects of paper. KH contributed in writing of all radiology part of manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.